DGX vs UHS
Quest Diagnostics Inc. and Universal Health Services Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DGX | UHS |
|---|---|---|
| Revenue | $11.0B | $17.4B |
| Net income | $992.0M | $1.5B |
| Gross margin | 33.2% | · |
| Net margin | 9.5% | 8.7% |
| Return on equity | 14.2% | 21.4% |
| Diluted EPS | $8.75 | $23.10 |
| Dividend / share | · | $0.80 |
| Payout ratio | 35.6% | 3.4% |
| Free cash flow | $1.4B | $849.2M |
| Equity | $7.2B | $7.3B |
| Net debt / equity | 0.73× | 0.63× |
| Current ratio | 1.04× | 1.05× |
| Revenue CAGR 5y | 3.2% | 8.5% |
| Profit CAGR 5y | −7.1% | 9.5% |
UHS bills 1.6× the revenue of DGX, and DGX keeps more of each dollar of revenue as profit (9.5% against 8.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | DGX | UHS |
|---|---|---|
| FY2025 | $11.0B | $17.4B |
| FY2024 | $9.9B | $15.8B |
| FY2023 | $9.3B | $14.3B |
| FY2022 | $9.9B | $13.4B |
| FY2021 | $10.8B | $12.6B |
| FY2020 | $9.4B | $11.6B |
| FY2019 | $7.7B | $11.4B |
| FY2018 | $7.5B | $10.8B |
| FY2017 | $7.4B | $10.4B |
| FY2016 | $7.2B | $9.8B |
Bottom line
| Fiscal year | DGX | UHS |
|---|---|---|
| FY2025 | $992.0M | $1.5B |
| FY2024 | $871.0M | $1.1B |
| FY2023 | $854.0M | $717.8M |
| FY2022 | $946.0M | $675.6M |
| FY2021 | $2.0B | $991.6M |
| FY2020 | $1.4B | $944.0M |
| FY2019 | $858.0M | $814.9M |
| FY2018 | $736.0M | $779.7M |
| FY2017 | $772.0M | $752.3M |
| FY2016 | $645.0M | $702.4M |
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$6,329,829,000 | UHS |
| FY2024 | −$5,955,935,000 | UHS |
| FY2023 | −$5,029,976,000 | UHS |
| FY2022 | −$3,516,370,000 | UHS |
| FY2021 | −$1,854,117,000 | UHS |
| FY2020 | −$2,121,897,000 | UHS |
| FY2019 | −$3,652,259,000 | UHS |
| FY2018 | −$3,241,278,000 | UHS |
| FY2017 | −$3,007,865,000 | UHS |
| FY2016 | −$2,552,210,000 | UHS |
| FY2015 | −$1,550,451,000 | UHS |
| FY2014 | −$770,088,000 | UHS |
| FY2013 | −$221,873,000 | UHS |
| FY2012 | +$421,600,000 | DGX |
| FY2011 | +$631,778,000 | DGX |
| FY2010 | +$2,359,973,000 | DGX |
| FY2009 | +$2,252,864,000 | DGX |
| FY2008 | +$2,227,030,000 | DGX |
The higher-revenue side has changed between DGX and UHS over this period. The gap has widened since the earliest year compared.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +0.8 pp | DGX |
| FY2024 | +2.0 pp | DGX |
| FY2023 | +4.8 pp | DGX |
| FY2022 | +5.4 pp | DGX |
| FY2021 | +11.5 pp | DGX |
| FY2020 | +7.6 pp | DGX |
| FY2019 | +4.5 pp | DGX |
| FY2018 | +3.1 pp | DGX |
| FY2017 | +3.7 pp | DGX |
| FY2016 | +2.0 pp | DGX |
| FY2015 | +1.7 pp | DGX |
| FY2014 | +0.6 pp | DGX |
| FY2013 | +4.8 pp | DGX |
| FY2012 | +1.0 pp | DGX |
| FY2011 | +0.2 pp | DGX |
| FY2010 | +4.8 pp | DGX |
| FY2009 | +4.4 pp | DGX |
| FY2008 | +3.7 pp | DGX |
DGX has kept the higher net margin in every one of these 18 fiscal years.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DGX's net margin has been more volatile than UHS's over the 18 comparable fiscal years — 2.8 percentage points of standard deviation against 1.2.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
DGX led in net margin in every one of the 18 comparable fiscal years — a structural lead, not a recent swing.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DGX's return on equity has been more volatile than UHS's over the 18 comparable fiscal years — 4.3 percentage points of standard deviation against 2.5.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between DGX and UHS over these 18 fiscal years — DGX led in 10 and UHS in 8.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.